Sociodemographic and clinical factors associated with dual disorders in a psychiatric hospital

Guillermo Alonso Castaño Pérez, Luz Angela Rojas Bernal, José Bareño Silva, Gloria María Sierra Hincapié

DOI: https://doi.org/10.17711/SM.0185-3325.2017.036

Abstract


Introduction. Among patients with mental illness, dual disorders patients are characterized by a heterogeneous and more severe clinical presentation that is difficult to treat. Therefore, knowledge about the distribution of this disorder and the characteristics of these patients can be helpful to optimize and organize health resources.

Objective. To explore the prevalence and socio-demographic and clinical factors associated with dual disorders patients who were hospitalized due to mental illness at a psychiatric unit in Colombia between January and June 2013; this data was collected and analyzed on the basis of the medical records of each patient.

Method. Observational, quantitative, cross-sectional study of a secondary source. It included the analysis of 201 patients aged 18 to 65.

Results. There were 201 patients analyzed; 45.3% had dual disorders, with a ratio of 2.24 men:women; there was a high frequency of single marital status (69.2%) and more than 90% had a low socioeconomic level. The factors significantly associated with dual disorders in order of importance were: age from 18 to 35 years (OR = 11.03; CI 95% [4.43, 27.46]), male (OR = 5.10, CI 95% [2.26, 11.50]), history of aggression (OR = 3.35; CI 95% [1.63, 6.91]), and readmission in the year after hospital discharge (OR = 2.23; CI 95% [1.08, 4.61]).

Discussion and conclusion. Dual disorders prevalence in this study is similar to that found by other authors. The high prevalence of dual disorders requires specialized therapeutic programs for treatment. The more hospitals know about the associated variables in this study, the more they will be able to improve their approach to patients.


Keywords


Dual disorders; associated factors; psychiatric hospital; cross-sectional studies

Full Text:

HTML Pdf ePub Xml

References


Appleby, L., Shaw, J., Amos, T., McDonnell, R., Harris, C., McCann, K. Parsons, R. (1999). Suicide within 12 months of contact with mental health services: national clinical survey. BMJ (Clinical Research Ed.), 318(7193), 1235-1239.

Ball, D. C., Tornaría, M. del L. G., del Arca, D., & Olson, D. H. (2016). Propiedades Psicométricas del FACES IV: Estudio de validez en población uruguaya. Ciencias Psicológicas, 7(1), 119-132.

Barnaby, B., Drummond, C., McCloud, A., Burns, T., & Omu, N. (2003). Substance misuse in psychiatric inpatients: comparison of a screening questionnaire survey with case notes. BMJ (Clinical Research Ed.), 327(7418), 783-784. https://doi.org/10.1136/bmj.327.7418.783

Brady, K., Casto, S., Lydiard, R. B., Malcolm, R., & Arana, G. (1991). Substance abuse in an inpatient psychiatric sample. The American Journal of Drug and Alcohol Abuse, 17(4), 389-397.

Brown, E. S. (2005). Bipolar disorder and substance abuse. The Psychiatric Clinics of North America, 28(2), 415-425. https://doi.org/10.1016/j.psc.2005.01.004

Cantor-Graae, E., Nordström, L. G., & McNeil, T. F. (2001). Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophrenia Research, 48(1), 69-82.

Cantwell, R., Brewin, J., Glazebrook, C., Dalkin, T., Fox, R., Medley, I., & Harrison, G. (1999). Prevalence of substance misuse in first-episode psychosis. The British Journal of Psychiatry: The Journal of Mental Science, 174, 150-153.

Carey, M. P., Carey, K. B., & Meisler, A. W. (1991). Psychiatric symptoms in mentally ill chemical abusers. The Journal of Nervous and Mental Disease, 179(3), 136-138.

Casas, M., Franco, M. D., Goikolea, J. M., Jiménez-Arriero, M. A., Martínez-Raga, J., Roncero, C. Spanish Working Group on Bipolar Disorders in Dual Diagnosis. (2008). Bipolar disorder associated to substance use disorders (dual diagnosis). Systematic review of the scientific evidence and expert consensus. Actas Espanolas De Psiquiatria, 36(6), 350-361.

Casas, Miguel. (2000). Trastornos duales. Trastornos afectivos: ansiedad y depresión (2nd ed). Barcelona [etc.: Masson.

Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 64(5), 566-576. https://doi.org/10.1001/archpsyc.64.5.566

Comtois, K. A., Tisdall, W. A., Holdcraft, L. C., & Simpson, T. (2005). Dual diagnosis: impact of family history. The American Journal on Addictions, 14(3), 291-299. https://doi.org/10.1080/10550490590949479

Dervaux, A., Bayle, F. J., & Krebs, M.-O. (2002). Substance misuse among people with schizophrenia: similarities and differences between the UK and France. The British Journal of Psychiatry: The Journal of Mental Science, 180, 381.

Dickey, B., Normand, S.-L. T., Weiss, R. D., Drake, R. E., & Azeni, H. (2002). Medical morbidity, mental illness, and substance use disorders. Psychiatric Services (Washington, D.C.), 53(7), 861-867. https://doi.org/10.1176/appi.ps.53.7.861

DiNitto, D. M., Webb, D. K., & Rubin, A. (2002). Gender differences in dually-diagnosed clients receiving chemical dependency treatment. Journal of Psychoactive Drugs, 34(1), 105-117. https://doi.org/10.1080/02791072.2002.10399942

Drake, R. E., & Mueser, K. T. (2000). Psychosocial approaches to dual diagnosis. Schizophrenia Bulletin, 26(1), 105-118.

Driessen, M., Veltrup, C., Wetterling, T., John, U., & Dilling, H. (1998). Axis I and axis II comorbidity in alcohol dependence and the two types of alcoholism. Alcoholism, Clinical and Experimental Research, 22(1), 77-86.

Dulit, R. A., Fyer, M. R., Haas, G. L., Sullivan, T., & Frances, A. J. (1990). Substance use in borderline personality disorder. The American Journal of Psychiatry, 147(8), 1002-1007. https://doi.org/10.1176/ajp.147.8.1002

Farris, C., Brems, C., Johnson, M. E., Wells, R., Burns, R., & Kletti, N. (2003). A comparison of schizophrenic patients with or without coexisting substance use disorder. The Psychiatric Quarterly, 74(3), 205-222.

Fenton, W. S. (2001). Comorbid conditions in schizophrenia. Current Opinion in Psychiatry, 14(1), 17-23.

George, T. P., & Krystal, J. H. (2000). Comorbidity of psychiatric and substance abuse disorders. Current Opinion in Psychiatry, 13(3), 327-331.

Gual, A. (2007). Dual diagnosis in Spain. Drug and Alcohol Review, 26(1), 65-71. https://doi.org/10.1080/09595230601037000

Havassy, B. E., & Arns, P. G. (1998). Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients. Psychiatric Services (Washington, D.C.), 49(7), 935-940. https://doi.org/10.1176/ps.49.7.935

Hintz, T., & Mann, K. (2005). Comorbidity in alcohol use disorders: focus on mood, anxiety and personality. En Dual Diagnosis (pp. 65-91). Karger Publishers.

Hunt, G. E., Bergen, J., & Bashir, M. (2002). Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophrenia Research, 54(3), 253-264.

Jiménez-Castro, L., Raventós-Vorst, H., & Escamilla, M. (2011). Substance use disorder and schizophrenia: prevalence and sociodemographic characteristics in the

Latin American population. Actas Espanolas De Psiquiatria, 39(2), 123-130.

Kamali, M., Kelly, L., Gervin, M., Browne, S., Larkin, C., & O’Callaghan, E. (2001). Psychopharmacology: insight and comorbid substance misuse and medication compliance among patients with schizophrenia. Psychiatric Services (Washington, D.C.), 52(2), 161-163, 166. https://doi.org/10.1176/appi.ps.52.2.161

Karam, E. G., Yabroudi, P. F., & Melhem, N. M. (2002). Comorbidity of substance abuse and other psychiatric disorders in acute general psychiatric admissions: a study from Lebanon. Comprehensive Psychiatry, 43(6), 463-468. https://doi.org/10.1053/comp.2002.35910

Lehman, A. F., Myers, C. P., Corty, E., & Thompson, J. W. (1994). Prevalence and patterns of «dual diagnosis» among psychiatric inpatients. Comprehensive Psychiatry, 35(2), 106-112.

Levin, F. R., & Hennessy, G. (2004). Bipolar disorder and substance abuse. Biological Psychiatry, 56(10), 738-748. https://doi.org/10.1016/j.biopsych.2004.05.008

López-Ibor Aliño, J. J., Valdés Miyar, M., & American Psychiatric Association. (2002). DSM-IV-TR: manual diagnóstico y estadístico de los trastornos mentales. Barcelona: Masson.

Margolese, H. C., Malchy, L., Negrete, J. C., Tempier, R., & Gill, K. (2004). Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophrenia Research, 67(2-3), 157-166. https://doi.org/10.1016/S0920-9964(02)00523-6

McCrone, P., Menezes, P. R., Johnson, S., Scott, H., Thornicroft, G., Marshall, J. Kuipers, E. (2000). Service use and costs of people with dual diagnosis in South London. Acta Psychiatrica Scandinavica, 101(6), 464-472.

McCrory, E. J., & Mayes, L. (2015). Understanding Addiction as a Developmental Disorder: An Argument for a Developmentally Informed Multilevel Approach. Current Addiction Reports, 2(4), 326-330. https://doi.org/10.1007/s40429-015-0079-2

McGrath, J. (2000). Universal interventions for the primary prevention of schizophrenia. The Australian and New Zealand Journal of Psychiatry, 34 Suppl, S58-64. https://doi.org/10.1080/000486700224

Mueser, K. T., Yarnold, P. R., Rosenberg, S. D., Swett, C., Miles, K. M., & Hill, D. (2000). Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups. Schizophrenia Bulletin, 26(1), 179-192.

Mueser, Kim T., Glynn, S. M., Cather, C., Zarate, R., Fox, L., Feldman, J., Clark, R. E. (2009). Family intervention for co-occurring substance use and severe psychiatric disorders: participant characteristics and correlates of initial engagement and more extended exposure in a randomized controlled trial. Addictive Behaviors, 34(10), 867-877. https://doi.org/10.1016/j.addbeh.2009.03.025

Olson, D. (2011). FACES IV and the Circumplex Model: validation study. Journal of Marital and Family Therapy, 37(1), 64-80. https://doi.org/10.1111/j.1752-0606.2009.00175.x

Otto, M. W., Pollack, M. H., Sachs, G. S., O’Neil, C. A., & Rosenbaum, J. F. (1992). Alcohol dependence in panic disorder patients. Journal of Psychiatric Research, 26(1), 29-38.

Patel, V., Chisholm, D., Parikh, R., Charlson, F. J., Degenhardt, L., Dua, T., DCP MNS Author Group. (2015). Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. Lancet (London, England). https://doi.org/10.1016/S0140-6736(15)00390-6

Pereiro, C., Pino, C., Flórez, G., Arrojo, M., Becoña, E., & COPSIAD Group. (2013). Psychiatric Comorbidity in Patients from the Addictive Disorders Assistance Units of Galicia: The COPSIAD Study. PloS One, 8(6), e66451. https://doi.org/10.1371/journal.pone.0066451

Primm, A. B., Gomez, M. B., Tzolova-Iontchev, I., Perry, W., Vu, H. T., & Crum, R. M. (2000). Mental health versus substance abuse treatment programs for dually diagnosed patients. Journal of Substance Abuse Treatment, 19(3), 285-290.

Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA, 264(19), 2511-2518.

Reissner, V., Kokkevi, A., Schifano, F., Room, R., Storbjörk, J., Stohler, R., Scherbaum, N. (2012). Differences in drug consumption, comorbidity and health service use of opioid addicts across six European urban regions (TREAT-project). European Psychiatry: The Journal of the Association of European Psychiatrists, 27(6), 455-462. https://doi.org/10.1016/j.eurpsy.2010.10.001

Rodríguez-Jiménez, R., Aragüés, M., Jiménez-Arriero, M. A., Ponce, G., Muñoz, A., Bagney, A., Palomo, T. (2008). [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics]. Investigacion Clinica, 49(2), 195-205.

Sanabria, M. A., Díaz, O., Varela, J., & Braña, T. (2002). Relevancia para el tratamiento de la sintomatología depresiva de los pacientes adictos. Adicciones, 14(1), 25-31.

Seedat, S., Scott, K. M., Angermeyer, M. C., Berglund, P., Bromet, E. J., Brugha, T. S., Kessler, R. C. (2009). Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Archives of General Psychiatry, 66(7), 785-795. https://doi.org/10.1001/archgenpsychiatry.2009.36

Soyka, M. (2000). Substance misuse, psychiatric disorder and violent and disturbed behaviour. The British Journal of Psychiatry: The Journal of Mental Science, 176, 345-350.

Swendsen, J., Conway, K. P., Degenhardt, L., Glantz, M., Jin, R., Merikangas, K. R., Kessler, R. C. (2010). Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction (Abingdon, England), 105(6), 1117-1128. https://doi.org/10.1111/j.1360-0443.2010.02902.x

Swindle, R. W., Phibbs, C. S., Paradise, M. J., Recine, B. P., & Moos, R. H. (1995). Inpatient treatment for substance abuse patients with psychiatric disorders: a national study of determinants of readmission. Journal of Substance Abuse, 7(1), 79-97.

Szerman, N., Martinez-Raga, J., Peris, L., Roncero, C., Basurte, I., Vega, P., Casas, M. (2013). Rethinking Dual Disorders/Pathology: Addictive Disorders & Their Treatment, 12(1), 1-10. https://doi.org/10.1097/ADT.0b013e31826e7b6a

Tómasson, K., & Vaglum, P. (1995). A nationwide representative sample of treatment-seeking alcoholics: a study of psychiatric comorbidity. Acta Psychiatrica Scandinavica, 92(5), 378-385.

Weaver, T., Madden, P., Charles, V., Stimson, G., Renton, A., Tyrer, P., Comorbidity of Substance Misuse and Mental Illness Collaborative study team. (2003). Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. The British Journal of Psychiatry: The Journal of Mental Science, 183, 304-313.

Woody, G. (1996). The challenge of dual diagnosis. Alcohol Research and Health, 20(2), 76.